In the same study, CD55 and CD46 were also shown to be moderately expressed in GBM cell lines, and neutralizing them with respective antibodies showed moderate complement-mediated cytolysis, although CD59 was considered to be the most important complement regulator on GBM cells (70). Here, CD55 is linked to glioblastoma.